US-guided ablation of tumors – where is it used and how did we get there
Abstract Ablation under ultrasound (US) guidance for the treatment of various tumors in liver, thyroid, prostate, kidney, uterine and many other organs evolved extensively in the past decades. Major ablative techniques, including radiofrequency ablation, microwave ablation, high intensity focused ul...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Wu, Jia-peng [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2023 |
|---|
| Schlagwörter: |
|---|
| Anmerkung: |
© The Author(s) 2023 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Med-X - Springer Nature Singapore, 2023, 1(2023), 1 vom: 11. Juli |
|---|---|
| Übergeordnetes Werk: |
volume:1 ; year:2023 ; number:1 ; day:11 ; month:07 |
| Links: |
|---|
| DOI / URN: |
10.1007/s44258-023-00002-2 |
|---|
| Katalog-ID: |
SPR052208222 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR052208222 | ||
| 003 | DE-627 | ||
| 005 | 20230711064750.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230711s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s44258-023-00002-2 |2 doi | |
| 035 | |a (DE-627)SPR052208222 | ||
| 035 | |a (SPR)s44258-023-00002-2-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wu, Jia-peng |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a US-guided ablation of tumors – where is it used and how did we get there |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s) 2023 | ||
| 520 | |a Abstract Ablation under ultrasound (US) guidance for the treatment of various tumors in liver, thyroid, prostate, kidney, uterine and many other organs evolved extensively in the past decades. Major ablative techniques, including radiofrequency ablation, microwave ablation, high intensity focused ultrasound, cryoablation, percutaneous ethanol injection, laser ablation and irreversible electroporation, have all been widely applied and ablation is recommended by several guidelines as first-line or alternative therapy e.g. hepatocellular carcinoma in early stage, T1a stage renal cell carcinoma and thyroid nodules. In the current article, we reviewed 2508 articles on tumor ablation under US guidance and present the status of US-guided tumor ablation globally. | ||
| 520 | |a Highlights Radiofrequency is the most used technique for ablation in solid tumors.Asia accounted more than a half in ultrasound-guided tumor ablation.Thyroid nodules have developed rapidly since 2010. | ||
| 650 | 4 | |a Ablation |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Ultrasound |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Tumor |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Yu, Jie |4 aut | |
| 700 | 1 | |a Fowlkes, J. Brian |4 aut | |
| 700 | 1 | |a Liang, Ping |4 aut | |
| 700 | 1 | |a Nolsøe, Christian Pállson |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Med-X |d Springer Nature Singapore, 2023 |g 1(2023), 1 vom: 11. Juli |w (DE-627)1845291662 |x 2731-8710 |7 nnns |
| 773 | 1 | 8 | |g volume:1 |g year:2023 |g number:1 |g day:11 |g month:07 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s44258-023-00002-2 |z kostenfrei |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 951 | |a AR | ||
| 952 | |d 1 |j 2023 |e 1 |b 11 |c 07 | ||
| author_variant |
j p w jpw j y jy j b f jb jbf p l pl c p n cp cpn |
|---|---|
| matchkey_str |
article:27318710:2023----::suddbainfuoshriiueado |
| hierarchy_sort_str |
2023 |
| publishDate |
2023 |
| allfields |
10.1007/s44258-023-00002-2 doi (DE-627)SPR052208222 (SPR)s44258-023-00002-2-e DE-627 ger DE-627 rakwb eng Wu, Jia-peng verfasserin aut US-guided ablation of tumors – where is it used and how did we get there 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s) 2023 Abstract Ablation under ultrasound (US) guidance for the treatment of various tumors in liver, thyroid, prostate, kidney, uterine and many other organs evolved extensively in the past decades. Major ablative techniques, including radiofrequency ablation, microwave ablation, high intensity focused ultrasound, cryoablation, percutaneous ethanol injection, laser ablation and irreversible electroporation, have all been widely applied and ablation is recommended by several guidelines as first-line or alternative therapy e.g. hepatocellular carcinoma in early stage, T1a stage renal cell carcinoma and thyroid nodules. In the current article, we reviewed 2508 articles on tumor ablation under US guidance and present the status of US-guided tumor ablation globally. Highlights Radiofrequency is the most used technique for ablation in solid tumors.Asia accounted more than a half in ultrasound-guided tumor ablation.Thyroid nodules have developed rapidly since 2010. Ablation (dpeaa)DE-He213 Ultrasound (dpeaa)DE-He213 Tumor (dpeaa)DE-He213 Yu, Jie aut Fowlkes, J. Brian aut Liang, Ping aut Nolsøe, Christian Pállson aut Enthalten in Med-X Springer Nature Singapore, 2023 1(2023), 1 vom: 11. Juli (DE-627)1845291662 2731-8710 nnns volume:1 year:2023 number:1 day:11 month:07 https://dx.doi.org/10.1007/s44258-023-00002-2 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER AR 1 2023 1 11 07 |
| spelling |
10.1007/s44258-023-00002-2 doi (DE-627)SPR052208222 (SPR)s44258-023-00002-2-e DE-627 ger DE-627 rakwb eng Wu, Jia-peng verfasserin aut US-guided ablation of tumors – where is it used and how did we get there 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s) 2023 Abstract Ablation under ultrasound (US) guidance for the treatment of various tumors in liver, thyroid, prostate, kidney, uterine and many other organs evolved extensively in the past decades. Major ablative techniques, including radiofrequency ablation, microwave ablation, high intensity focused ultrasound, cryoablation, percutaneous ethanol injection, laser ablation and irreversible electroporation, have all been widely applied and ablation is recommended by several guidelines as first-line or alternative therapy e.g. hepatocellular carcinoma in early stage, T1a stage renal cell carcinoma and thyroid nodules. In the current article, we reviewed 2508 articles on tumor ablation under US guidance and present the status of US-guided tumor ablation globally. Highlights Radiofrequency is the most used technique for ablation in solid tumors.Asia accounted more than a half in ultrasound-guided tumor ablation.Thyroid nodules have developed rapidly since 2010. Ablation (dpeaa)DE-He213 Ultrasound (dpeaa)DE-He213 Tumor (dpeaa)DE-He213 Yu, Jie aut Fowlkes, J. Brian aut Liang, Ping aut Nolsøe, Christian Pállson aut Enthalten in Med-X Springer Nature Singapore, 2023 1(2023), 1 vom: 11. Juli (DE-627)1845291662 2731-8710 nnns volume:1 year:2023 number:1 day:11 month:07 https://dx.doi.org/10.1007/s44258-023-00002-2 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER AR 1 2023 1 11 07 |
| allfields_unstemmed |
10.1007/s44258-023-00002-2 doi (DE-627)SPR052208222 (SPR)s44258-023-00002-2-e DE-627 ger DE-627 rakwb eng Wu, Jia-peng verfasserin aut US-guided ablation of tumors – where is it used and how did we get there 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s) 2023 Abstract Ablation under ultrasound (US) guidance for the treatment of various tumors in liver, thyroid, prostate, kidney, uterine and many other organs evolved extensively in the past decades. Major ablative techniques, including radiofrequency ablation, microwave ablation, high intensity focused ultrasound, cryoablation, percutaneous ethanol injection, laser ablation and irreversible electroporation, have all been widely applied and ablation is recommended by several guidelines as first-line or alternative therapy e.g. hepatocellular carcinoma in early stage, T1a stage renal cell carcinoma and thyroid nodules. In the current article, we reviewed 2508 articles on tumor ablation under US guidance and present the status of US-guided tumor ablation globally. Highlights Radiofrequency is the most used technique for ablation in solid tumors.Asia accounted more than a half in ultrasound-guided tumor ablation.Thyroid nodules have developed rapidly since 2010. Ablation (dpeaa)DE-He213 Ultrasound (dpeaa)DE-He213 Tumor (dpeaa)DE-He213 Yu, Jie aut Fowlkes, J. Brian aut Liang, Ping aut Nolsøe, Christian Pállson aut Enthalten in Med-X Springer Nature Singapore, 2023 1(2023), 1 vom: 11. Juli (DE-627)1845291662 2731-8710 nnns volume:1 year:2023 number:1 day:11 month:07 https://dx.doi.org/10.1007/s44258-023-00002-2 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER AR 1 2023 1 11 07 |
| allfieldsGer |
10.1007/s44258-023-00002-2 doi (DE-627)SPR052208222 (SPR)s44258-023-00002-2-e DE-627 ger DE-627 rakwb eng Wu, Jia-peng verfasserin aut US-guided ablation of tumors – where is it used and how did we get there 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s) 2023 Abstract Ablation under ultrasound (US) guidance for the treatment of various tumors in liver, thyroid, prostate, kidney, uterine and many other organs evolved extensively in the past decades. Major ablative techniques, including radiofrequency ablation, microwave ablation, high intensity focused ultrasound, cryoablation, percutaneous ethanol injection, laser ablation and irreversible electroporation, have all been widely applied and ablation is recommended by several guidelines as first-line or alternative therapy e.g. hepatocellular carcinoma in early stage, T1a stage renal cell carcinoma and thyroid nodules. In the current article, we reviewed 2508 articles on tumor ablation under US guidance and present the status of US-guided tumor ablation globally. Highlights Radiofrequency is the most used technique for ablation in solid tumors.Asia accounted more than a half in ultrasound-guided tumor ablation.Thyroid nodules have developed rapidly since 2010. Ablation (dpeaa)DE-He213 Ultrasound (dpeaa)DE-He213 Tumor (dpeaa)DE-He213 Yu, Jie aut Fowlkes, J. Brian aut Liang, Ping aut Nolsøe, Christian Pállson aut Enthalten in Med-X Springer Nature Singapore, 2023 1(2023), 1 vom: 11. Juli (DE-627)1845291662 2731-8710 nnns volume:1 year:2023 number:1 day:11 month:07 https://dx.doi.org/10.1007/s44258-023-00002-2 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER AR 1 2023 1 11 07 |
| allfieldsSound |
10.1007/s44258-023-00002-2 doi (DE-627)SPR052208222 (SPR)s44258-023-00002-2-e DE-627 ger DE-627 rakwb eng Wu, Jia-peng verfasserin aut US-guided ablation of tumors – where is it used and how did we get there 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s) 2023 Abstract Ablation under ultrasound (US) guidance for the treatment of various tumors in liver, thyroid, prostate, kidney, uterine and many other organs evolved extensively in the past decades. Major ablative techniques, including radiofrequency ablation, microwave ablation, high intensity focused ultrasound, cryoablation, percutaneous ethanol injection, laser ablation and irreversible electroporation, have all been widely applied and ablation is recommended by several guidelines as first-line or alternative therapy e.g. hepatocellular carcinoma in early stage, T1a stage renal cell carcinoma and thyroid nodules. In the current article, we reviewed 2508 articles on tumor ablation under US guidance and present the status of US-guided tumor ablation globally. Highlights Radiofrequency is the most used technique for ablation in solid tumors.Asia accounted more than a half in ultrasound-guided tumor ablation.Thyroid nodules have developed rapidly since 2010. Ablation (dpeaa)DE-He213 Ultrasound (dpeaa)DE-He213 Tumor (dpeaa)DE-He213 Yu, Jie aut Fowlkes, J. Brian aut Liang, Ping aut Nolsøe, Christian Pállson aut Enthalten in Med-X Springer Nature Singapore, 2023 1(2023), 1 vom: 11. Juli (DE-627)1845291662 2731-8710 nnns volume:1 year:2023 number:1 day:11 month:07 https://dx.doi.org/10.1007/s44258-023-00002-2 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER AR 1 2023 1 11 07 |
| language |
English |
| source |
Enthalten in Med-X 1(2023), 1 vom: 11. Juli volume:1 year:2023 number:1 day:11 month:07 |
| sourceStr |
Enthalten in Med-X 1(2023), 1 vom: 11. Juli volume:1 year:2023 number:1 day:11 month:07 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Ablation Ultrasound Tumor |
| isfreeaccess_bool |
true |
| container_title |
Med-X |
| authorswithroles_txt_mv |
Wu, Jia-peng @@aut@@ Yu, Jie @@aut@@ Fowlkes, J. Brian @@aut@@ Liang, Ping @@aut@@ Nolsøe, Christian Pállson @@aut@@ |
| publishDateDaySort_date |
2023-07-11T00:00:00Z |
| hierarchy_top_id |
1845291662 |
| id |
SPR052208222 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">SPR052208222</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230711064750.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230711s2023 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s44258-023-00002-2</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR052208222</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s44258-023-00002-2-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Wu, Jia-peng</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">US-guided ablation of tumors – where is it used and how did we get there</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2023</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© The Author(s) 2023</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Ablation under ultrasound (US) guidance for the treatment of various tumors in liver, thyroid, prostate, kidney, uterine and many other organs evolved extensively in the past decades. Major ablative techniques, including radiofrequency ablation, microwave ablation, high intensity focused ultrasound, cryoablation, percutaneous ethanol injection, laser ablation and irreversible electroporation, have all been widely applied and ablation is recommended by several guidelines as first-line or alternative therapy e.g. hepatocellular carcinoma in early stage, T1a stage renal cell carcinoma and thyroid nodules. In the current article, we reviewed 2508 articles on tumor ablation under US guidance and present the status of US-guided tumor ablation globally.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Highlights Radiofrequency is the most used technique for ablation in solid tumors.Asia accounted more than a half in ultrasound-guided tumor ablation.Thyroid nodules have developed rapidly since 2010.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ablation</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ultrasound</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tumor</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yu, Jie</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fowlkes, J. Brian</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Liang, Ping</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nolsøe, Christian Pállson</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Med-X</subfield><subfield code="d">Springer Nature Singapore, 2023</subfield><subfield code="g">1(2023), 1 vom: 11. Juli</subfield><subfield code="w">(DE-627)1845291662</subfield><subfield code="x">2731-8710</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1</subfield><subfield code="g">year:2023</subfield><subfield code="g">number:1</subfield><subfield code="g">day:11</subfield><subfield code="g">month:07</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s44258-023-00002-2</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1</subfield><subfield code="j">2023</subfield><subfield code="e">1</subfield><subfield code="b">11</subfield><subfield code="c">07</subfield></datafield></record></collection>
|
| author |
Wu, Jia-peng |
| spellingShingle |
Wu, Jia-peng misc Ablation misc Ultrasound misc Tumor US-guided ablation of tumors – where is it used and how did we get there |
| authorStr |
Wu, Jia-peng |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)1845291662 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut aut aut |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
2731-8710 |
| topic_title |
US-guided ablation of tumors – where is it used and how did we get there Ablation (dpeaa)DE-He213 Ultrasound (dpeaa)DE-He213 Tumor (dpeaa)DE-He213 |
| topic |
misc Ablation misc Ultrasound misc Tumor |
| topic_unstemmed |
misc Ablation misc Ultrasound misc Tumor |
| topic_browse |
misc Ablation misc Ultrasound misc Tumor |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Med-X |
| hierarchy_parent_id |
1845291662 |
| hierarchy_top_title |
Med-X |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)1845291662 |
| title |
US-guided ablation of tumors – where is it used and how did we get there |
| ctrlnum |
(DE-627)SPR052208222 (SPR)s44258-023-00002-2-e |
| title_full |
US-guided ablation of tumors – where is it used and how did we get there |
| author_sort |
Wu, Jia-peng |
| journal |
Med-X |
| journalStr |
Med-X |
| lang_code |
eng |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2023 |
| contenttype_str_mv |
txt |
| author_browse |
Wu, Jia-peng Yu, Jie Fowlkes, J. Brian Liang, Ping Nolsøe, Christian Pállson |
| container_volume |
1 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Wu, Jia-peng |
| doi_str_mv |
10.1007/s44258-023-00002-2 |
| title_sort |
us-guided ablation of tumors – where is it used and how did we get there |
| title_auth |
US-guided ablation of tumors – where is it used and how did we get there |
| abstract |
Abstract Ablation under ultrasound (US) guidance for the treatment of various tumors in liver, thyroid, prostate, kidney, uterine and many other organs evolved extensively in the past decades. Major ablative techniques, including radiofrequency ablation, microwave ablation, high intensity focused ultrasound, cryoablation, percutaneous ethanol injection, laser ablation and irreversible electroporation, have all been widely applied and ablation is recommended by several guidelines as first-line or alternative therapy e.g. hepatocellular carcinoma in early stage, T1a stage renal cell carcinoma and thyroid nodules. In the current article, we reviewed 2508 articles on tumor ablation under US guidance and present the status of US-guided tumor ablation globally. Highlights Radiofrequency is the most used technique for ablation in solid tumors.Asia accounted more than a half in ultrasound-guided tumor ablation.Thyroid nodules have developed rapidly since 2010. © The Author(s) 2023 |
| abstractGer |
Abstract Ablation under ultrasound (US) guidance for the treatment of various tumors in liver, thyroid, prostate, kidney, uterine and many other organs evolved extensively in the past decades. Major ablative techniques, including radiofrequency ablation, microwave ablation, high intensity focused ultrasound, cryoablation, percutaneous ethanol injection, laser ablation and irreversible electroporation, have all been widely applied and ablation is recommended by several guidelines as first-line or alternative therapy e.g. hepatocellular carcinoma in early stage, T1a stage renal cell carcinoma and thyroid nodules. In the current article, we reviewed 2508 articles on tumor ablation under US guidance and present the status of US-guided tumor ablation globally. Highlights Radiofrequency is the most used technique for ablation in solid tumors.Asia accounted more than a half in ultrasound-guided tumor ablation.Thyroid nodules have developed rapidly since 2010. © The Author(s) 2023 |
| abstract_unstemmed |
Abstract Ablation under ultrasound (US) guidance for the treatment of various tumors in liver, thyroid, prostate, kidney, uterine and many other organs evolved extensively in the past decades. Major ablative techniques, including radiofrequency ablation, microwave ablation, high intensity focused ultrasound, cryoablation, percutaneous ethanol injection, laser ablation and irreversible electroporation, have all been widely applied and ablation is recommended by several guidelines as first-line or alternative therapy e.g. hepatocellular carcinoma in early stage, T1a stage renal cell carcinoma and thyroid nodules. In the current article, we reviewed 2508 articles on tumor ablation under US guidance and present the status of US-guided tumor ablation globally. Highlights Radiofrequency is the most used technique for ablation in solid tumors.Asia accounted more than a half in ultrasound-guided tumor ablation.Thyroid nodules have developed rapidly since 2010. © The Author(s) 2023 |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER |
| container_issue |
1 |
| title_short |
US-guided ablation of tumors – where is it used and how did we get there |
| url |
https://dx.doi.org/10.1007/s44258-023-00002-2 |
| remote_bool |
true |
| author2 |
Yu, Jie Fowlkes, J. Brian Liang, Ping Nolsøe, Christian Pállson |
| author2Str |
Yu, Jie Fowlkes, J. Brian Liang, Ping Nolsøe, Christian Pállson |
| ppnlink |
1845291662 |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| doi_str |
10.1007/s44258-023-00002-2 |
| up_date |
2024-07-04T01:47:51.014Z |
| _version_ |
1803611192443273216 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">SPR052208222</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230711064750.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230711s2023 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s44258-023-00002-2</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR052208222</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s44258-023-00002-2-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Wu, Jia-peng</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">US-guided ablation of tumors – where is it used and how did we get there</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2023</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© The Author(s) 2023</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Ablation under ultrasound (US) guidance for the treatment of various tumors in liver, thyroid, prostate, kidney, uterine and many other organs evolved extensively in the past decades. Major ablative techniques, including radiofrequency ablation, microwave ablation, high intensity focused ultrasound, cryoablation, percutaneous ethanol injection, laser ablation and irreversible electroporation, have all been widely applied and ablation is recommended by several guidelines as first-line or alternative therapy e.g. hepatocellular carcinoma in early stage, T1a stage renal cell carcinoma and thyroid nodules. In the current article, we reviewed 2508 articles on tumor ablation under US guidance and present the status of US-guided tumor ablation globally.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Highlights Radiofrequency is the most used technique for ablation in solid tumors.Asia accounted more than a half in ultrasound-guided tumor ablation.Thyroid nodules have developed rapidly since 2010.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ablation</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ultrasound</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tumor</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yu, Jie</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fowlkes, J. Brian</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Liang, Ping</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nolsøe, Christian Pállson</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Med-X</subfield><subfield code="d">Springer Nature Singapore, 2023</subfield><subfield code="g">1(2023), 1 vom: 11. Juli</subfield><subfield code="w">(DE-627)1845291662</subfield><subfield code="x">2731-8710</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1</subfield><subfield code="g">year:2023</subfield><subfield code="g">number:1</subfield><subfield code="g">day:11</subfield><subfield code="g">month:07</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s44258-023-00002-2</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1</subfield><subfield code="j">2023</subfield><subfield code="e">1</subfield><subfield code="b">11</subfield><subfield code="c">07</subfield></datafield></record></collection>
|
| score |
7.4008694 |